ABSTRACT
INTRODUCTION
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1,2 Moreover, 37% of SCI patients develop pressure ulcers during their acute care hospitalization. 3 Factors contributing to PrUs are immobility, moisture and irritation to the skin. 4 Management of PrUs includes skin checks, proper seating systems, offloading pressureprone areas by positioning, and healthy nutrition and surgery. Surgical restoration uses flap techniques such as fasciocutaneous or myocutaneous flaps. Conventional dressing therapy after the initial surgical debridement consists of moist gauzes saturated with topical agents like sodium hypochlorite. Furthermore, foams, hydrocolloids, hydrogels and transparent film dressing are used. Vacuum-assisted closure (VAC) is a system that promotes the healing of wounds. VAC is based on the principal that negative pressure applied to the wound will promote an improved environment for wound healing. 6 The VAC system applies topical negative pressure to the wound using a polyurethane reticulated opencell foam dressing, or a polyvinyl alcohol foam dressing. When VAC is applied to the area under negative pressure conditions, the tissue promotes cell mitosis and proliferation of reparative granulation tissue. 7 In this research, data from the scientific literature on PrUs in patients with SCI were presented. The aim of this work was to review the role of VAC in PrUs of SCI patients.
MATERIALS AND METHODS
The study has been designed and the results have been reported based on the PRISMA statement (see Supplementary Checklist). 8 This review included prospective non-randomized trial, randomized, assessor-blinded crossover pilot, retrospective observational cohort study, randomized controlled trial and case study involving patients with PrUs and SCI, and the treatments. We searched the following databases: CINAHL, PubMed, Cochrane EBM Reviews, Cochrane Clinical Trials, DARE, MEDLINE, Scopus, Embase, Science Direct, PsycInfo and Spinal Cord Journal.
Search terms were "PrUs" AND "VAC" OR "SCI". These studies excluded: (i) studies not providing data on baseline score or end-point outcome, and (ii) studies providing only qualitative data. Data extraction was undertaken separately for each intervention. All relevant information was extracted for each study: first author, year of publication, type of study, study duration, age of patients, location of ulcer, number of patients, types of therapy and complications. The search was limited to English language articles. The reference lists of the included articles have also been searched for additional studies. Figure 1 shows the search algorithm. An overview of trial characteristics is provided in Table 1 , where most of the patients had pressure ulcers in the ischial tuberosities, stage 3 and 4. The total patient/ participant's population was 224, the range of age was 16-87 years (mean: 48.3) and the therapies included multiple variations of VAC, such as topical negative pressure/device (TNP/TND) and negative pressure wound therapy (NPWT).
RESULTS
The healing time differed in our studies, from 1 month to almost 2 years. A homogenous result was found in the changes of VAC dressings that were done approximately once to thrice a week, which was demonstrated in Table 2 . The time of discharge of the patients after admission was only referred in 2 articles, where both of them had a similar outcome of 3 months. Table 2 refers to the articles which included information about either time to heal, changes of VAC dressings or time of discharge after admission. 
DISCUSSION
The purpose of our study was to review the role of VAC in SCI-patients with PrUs. Seven articles that fulfilled this purpose were found. VAC was more commonly used in ischial tuberosities ulcers needing changes up to 3 times per week and time to discharge approximately 3 months. According to clinical and laboratory experience, the VAC system helped removing interstitial fluid from wounds, decreasing bacterial colonization and increasing wound vascularity. VAC can be used in a variety of diseases such as chronic open wounds which appear and are a common problem in patients with spinal cord injury, in postoperative spinal surgical infections and in diabetic ulcers. 9 It is safe to use for the management of infected wounds, open fracture wounds and related soft tissues complications and acute soft tissue wounds. 10 Although most of the patients had PrUs near the ischium, they were cases where patients had pressure ulcers on the feet and on the rather difficult to heal area of the sacrum. 11 Nonetheless, the results in all studies/cases were satisfying. Furthermore, VAC devices were indicated for serious traumatic and dehisced wounds. In addition, VAC used in posttraumatic injuries as a therapy of infections had also been referred to, because of its great antimicrobial agents. Lastly, VAC therapy used in pressure ulcers not only in SCI patients, but patients in general lead to a considerable decrease in costs, due to a cutback in resource utilization, like inpatient care, antibacterial agents and outpatient treatment visits. 11 We found that by using VAC treatment patients had indeed shorter curing time than those who were using regular therapies as the median treatment time with VAC was shown to be shorter than the corresponding time in the group with the traditional medication. In addition, SCI patients who received negative pressure as therapy showed faster reduction in size and depth of the ulcers as well as faster granulation tissue formation in contrast to the SCI patients with standard care.
The changes of the dressings were also different, for example in the treatment group with conventional dressings, changes had to be done 2-3 times a day versus the changes in the VAC-treatment group which were approximately 1-3 times a week. 12 Last, a greater decrease was Several limitations were needed to be considered, when interpreting the results of this study. First of all, the studies themselves were being non-randomized and small in the patients' number, thus having a small sample size. Secondly, the unsuccessful meta-analysis of the complete study itself has to be noted. Another point which has to be considered is the withdrawal of some patients from the trials, due to complications caused by the use of VAC. Lastly, the VAC therapy shows a great limitation in its use in ulcers near the low sacrum, where it cannot be easily applied. 12 Despite the findings of our research that support the use of VAC, further studies which include more randomized trials will be needed in order to fully support and determine the clinical and cost-effectiveness of VAC therapy in comparison with other treatments. The studies we included in our qualitative synthesis show that VAC improves the curing of PrUs in individuals with SCI and reduces the overall curing time and stay-in-hospital length as well as in-hospital complications. 13 The VAC technique is secure for home use, simple to apply and is competent in chronic wounds in patients not only with SCI, but also in sufferers with pressure ulcer, caused by diabetes, infections and posttraumatic injuries. 
